Browsing byAuthorMun, Yeung-Chul

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 31 to 60 of 60

Issue DateTitleAuthor(s)Type
2011Matched-Pair Analysis Comparing Outcomes of Second Autologous Stem Cell Transplantation and Chemotherapy As a Salvage Therapy in Patients with Multiple Myeloma Who Relapsed After Front-Line Autologous Stem Cell Transplantation문영철Meeting Abstract
2011Nilotinib Combined with Multi-Agent Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Interim Results of Korean Adult ALL Working Party Phase 2 Study문영철Meeting Abstract
2015Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia문영철Article
2023Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170)문영철Article
2020Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia문영철Article
2007Outgrowing endothelial cells that are derived from human umbilical cord blood improve neovascularization in hind-limb ischemia.성주명; 유은선; 권기환; 이경은; 문영철Meeting Abstract
2020Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)문영철Article
2015Predictive Value of 3-Month Early Molecular Response in New Chronic Phase Chronic Myeloid Leukemia Patients Treated with Radotinib문영철Meeting Abstract
2016Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome성주명; 문영철Article
2012Prospective Cohort Study with Risk-Adapted Central Nervous System (CNS) Evaluation in Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Analysis of Incidence and Risk Factors for Secondary CNS Involvement.문영철Meeting Abstract
2009Reactive Oxygen Species Might Have Important Roles On Angiogenesis of Endothelial Progenitor Cells Derived From HCB(Human Cord Blood) Which Are Stimulated by VEGF.성주명; 유은선; 이경은; 문영철; 남은미Meeting Abstract
2022Real-World Outcomes of Ruxolitinib in Patients With Myelofibrosis Focusing on Red Blood Cell Transfusion: A Multicenter Study From the MPN Working Party of the Korean Society of Hematology문영철Article
2020Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia문영철Article
2007Restoration of peroxiredoxins and catalase is closely correlated with the level of Philadelphia chromosome during imatinib therapy in CML성주명; 이서구; 유은선; 허정원; 이경은; 문영철; 우현애Meeting Abstract
2021Risk factors for neutropenic fever in non-Hodgkin's lymphoma patients with primary granulocyte colony-stimulating factor prophylaxis문영철Article
2012Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Chemotherapy Followed by High-Dose Therapy with ASCT for Newly Diagnosed Multiple Myeloma; Open-Labeled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis.문영철Meeting Abstract
2011Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Induction Chemotherapy Followed by High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma; Open-Labelled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis문영철Meeting Abstract
2021The 2020 revision of the guidelines for the management of myeloproliferative neoplasms문영철Review
2016The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea문영철Article
2007The clinical outcomes of autologous stem cell transplantation in peripheral T cell lymphoma: From retrospective Multicenter study in Korea.문영철Meeting Abstract
2018The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma문영철Article
2020The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study)문영철Article
2007The equal activity of azacytidine in 4 risk groups of IPSS in MDS문영철Meeting Abstract
2006The intention to treat analysis of the different post remission therapy modalities in AML patients with the "Intermediate Risk Group (IPG)" based on cytogenetics.성주명; 문영철Meeting Abstract
2009The Level of Peroxiredoxin and Catalase On Single Cell Level Is Correlated with the Positivity of Ph Chromosome in the Bone Marrow of CML Patients During Imatinib Therapy.성주명; 이서구; 유은선; 허정원; 이경은; 문영철; 남은미; 우현애Meeting Abstract
2006The LTB4 receptor is involved not only in the downstream pathway of rhG-CSF mobilization but in the LTB4 mobitization pathway in C57BL/6 mice.이순남; 성주명; 유은선; 이경은; 문영철Meeting Abstract
2015The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea문영철Article
2014Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer이순남; 성순희; 성주명; 이경은; 문영철; 남은미Article
2015Varicella-zoster virus-specific cell-mediated immunity and herpes zoster development in multiple myeloma patients receiving bortezomib- or thalidomide-based chemotherapy문영철Article
2010VEGFA and VEGFR2 Genetic Polymorphisms and Survival In Patients with Diffuse Large B Cell Lymphoma정화순; 문영철Meeting Abstract

BROWSE